Clinical Trial Update: A Phase I Study of TRN501 in Healthy Volunteers [Phase 1]

View source ↗

Summary

This update reports the completion of a Phase 1 study of TRN501 in healthy volunteers, with Parkinson disease listed as the condition.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Parkinson Disease

Drugs mentioned

• TRN501

Snippet

Sponsor: SNLD, Ltd. | Conditions: Parkinson Disease | Phase 1 | Status: COMPLETED